Wanda Williams

Statistics

Publications

Citations

120

H-Index

Active since

1992

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

Wanda Williams is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in pharmacology, ligand binding, and medicinal chemistry.

Publications per year

1992–2000

Publications

Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at .sigma. receptors. 2. Piperazines, bicyclic amines, bridged bicyclic amines, and miscellaneous compounds

Brian R. de Costa, Xiaoshu He, Joannes T. M. Linders et al. · Journal of Medicinal Chemistry · 1993 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediamines as .sigma. receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes

Brian R. de Costa, Celia Dominguez, Xiao Shu He et al. · Journal of Medicinal Chemistry · 1992 · 38 citations · Full text

Medicine, Chemistry, Pharmacology +8

A sigma-1 receptor selective analogue of BD1008. a potential substitute for (+)-opioids in sigma receptor binding assays

Dean Y. Maeda, Wanda Williams, Wayne D. Bowen et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

1–3 of 3